# Table 6 Costs, cost difference, and net monetary benefit for different input parameters, 80 year time horizon

From: Cost burden and net monetary benefit loss of neonatal hypoglycaemia

Utility Source and Method | Cost method | Discount Rate | Prevalence Source | Cost, NZ$, Hospital and Post-Discharge | Utility, QALYs | Net Monetary Benefit Loss, NZ$ | ||||
---|---|---|---|---|---|---|---|---|---|---|

Neonatal Hypoglycaemia | No Neonatal Hypoglycaemia | Difference | Neonatal Hypoglycaemia | No Neonatal Hypoglycaemia | λ = $43 k | λ = $14 k | ||||

Kwon et al., minimum value | Outcome with greatest cost | 3.5% | Mean, all outcomes | $72,233.42 | $6175.89 | $66,057.53 | 21.25 | 23.89 | $180,252.41 | $103,775.53 |

Kwon et al., minimum value | Sum of all outcomes | 3.5% | Mean, all outcomes | $71,847.80 | $6137.82 | $65,709.97 | 21.25 | 23.89 | $179,906.51 | $104,723.87 |

Kwon et al., product of values | Outcome with greatest cost | 3.5% | Mean, all outcomes | $71,928.23 | $6155.35 | $65,772.88 | 21.19 | 23.89 | $182,624.71 | $111,480.44 |

Petrou et al., minimum value | Outcome with greatest cost | 3.5% | Mean, all outcomes | $72,478.70 | $6193.92 | $66,284.79 | 22.08 | 25.22 | $201,874.00 | $99,124.63 |

Carrol et al., TTO, minimum value | Outcome with greatest cost | 3.5% | Mean, all outcomes | $72,147.79 | $6166.69 | $65,981.10 | 25.09 | 27.39 | $165,411.90 | $98,896.91 |

Carrol et al., SG, minimum value | Outcome with greatest cost | 3.5% | Mean, all outcomes | $71,866.26 | $6188.04 | $65,678.22 | 25.09 | 27.39 | $165,335.51 | $287,808.34 |

Kwon et al., minimum value | Outcome with greatest cost | 0.0% | Mean, all outcomes | $193,484.20 | $15,707.46 | $177,776.74 | 61.41 | 69.04 | $507,875.19 | $78,883.76 |

Kwon et al., minimum value | Outcome with greatest cost | 5.0% | Mean, all outcomes | $55,431.26 | $4859.70 | $50,571.56 | 15.79 | 17.76 | $135,510.35 | $33,429.72 |

Kwon et al., minimum value | Outcome with greatest cost | 3.5% | Minimum, all outcomes | $30,945.31 | $6208.07 | $24,737.24 | 23.29 | 23.89 | $50,818.36 | $106,689.74 |

Kwon et al., minimum value | Outcome with greatest cost | 3.5% | Mean, with vision disorders and epilepsy values equal to population without hypoglycaemia | $73,723.28 | $6188.28 | $67,534.99 | 21.18 | 23.89 | $184,998.44 | $103,775.53 |